Communicate the risk as well as the promise of weight-loss drugs
Briefly

The recent study on semaglutide not only emphasizes the drug's weight-loss capabilities but also reveals its potential in alleviating knee osteoarthritis pain, marking a notable advancement in treatment options.
While semaglutide presents significant benefits in managing osteoarthritis, the portrayal of its effects as 'life-changing' could lead to unrealistic expectations among patients seeking relief.
Read at Nature
[
|
]